Mechanism of Action of Ultomiris
Introduction Ultomiris is the brand name of ravulizumab-cwvz, a long-acting complement inhibitor. Pharmacologically, ravulizumab is a humanized monoclonal antibody that binds complement protein C5 and prevents terminal complement activation. The complement system is part of innate immunity. It helps destroy pathogens and damaged cells through inflammatory mediators and formation of the membrane attack complex, also … Read more